Craft

ResMed

Stock Price

$147.9

2023-09-08

Market Capitalization

$21.8 B

2023-09-08

Revenue

$4.2 B

FY, 2023

ResMed Summary

Company Summary

Overview
ResMed is a company that specializes in digital health and cloud-connected medical devices. It operates in two segments, the Sleep and Respiratory Care segment and the Software as a Service (SaaS). The company develops, manufactures, and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. ResMed offers a number of products, including airflow generators, diagnostic products, mask systems, cloud-connected CPAP machines, cloud-connected ventilators, portable oxygen, headgear, and other accessories. Furthermore, the company provides a network of out-of-hospital healthcare management solutions designed to help providers deliver personalized care.
Type
Public
Status
Active
Founded
1989
HQ
San Diego, CA, US | view all locations
Website
http://www.resmed.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Michael Mick Farrell

    Michael Mick Farrell, CEO

    • Rob Douglas

      Rob Douglas, President and Chief Operating Officer

    • David Pendarvis

      David Pendarvis, Chief Administrative Officer, Global General Counsel

    • Jim Hollingshead

      Jim Hollingshead, President, Sleep Business

    Operating MetricsView all

    Patents (US)

    598
    4.9%

    FY, 2021

    Patents (Foreign)

    1.4K
    2.0%

    FY, 2021

    Patents Pending

    8.3K
    33.9%

    FY, 2021

    LocationsView all

    22 locations detected

    • San Diego, CA HQ

      United States

      9001 Spectrum Center Blvd

    • Bella Vista, New South Wales

      Australia

      1 Elizabeth Macarthur Dr

    • Kontich, Vlaanderen

      Belgium

      50 Grote Steenweg

    • São Paulo, SP

      Brazil

      Roque Petroni Junior Avenue, 850 Bacaetava Tower

    • Chaoyang, Beijing Shi

      China

      12th Floor, Building, 12 Taiyanggong Middle Rd, Chaoyang Qu

    • Espoo

      Finland

      3 Hevosenkenkä

    and 16 others

    ResMed Financials

    Summary Financials

    Revenue (FY, 2023)
    $4.2B
    Gross profit (FY, 2023)
    $2.4B
    Net income (FY, 2023)
    $897.6M
    Cash (FY, 2023)
    $227.9M
    EBIT (FY, 2023)
    $1.1B
    Enterprise value
    $23.0B

    Footer menu